Gilead Sciences (GILD) Assets Average (2009 - 2026)

Gilead Sciences has reported Assets Average for 18 years, with the latest figure at $57.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average changed 0.11% year-over-year to $57.7 billion; the trailing twelve-month figure through Mar 2026 stood at $57.7 billion (changed 0.11% YoY), and the FY2025 full-year result was $59.0 billion, down 2.56% from the prior year.
• Assets Average for Q1 2026 stood at $57.7 billion, down from $58.8 billion in the prior quarter.
• The five-year high for Assets Average was $65.5 billion in Q1 2022, with the low at $54.1 billion in Q3 2024.
• Historically, Assets Average has averaged $59.7 billion across 5 years, with a median of $59.2 billion in 2024.
• Annual changes were most pronounced in 2024 — Assets Average decreased 13.32% — and 2025, when it increased 5.69%.
• Gilead Sciences' Assets Average stood at $62.9 billion in 2022, then retreated by 0.98% to $62.2 billion in 2023, then slipped by 8.82% to $56.8 billion in 2024, then increased by 3.56% to $58.8 billion in 2025, then declined by 1.92% to $57.7 billion in 2026.
• The last three Assets Average figures came in at $57.7 billion (Q1 2026), $58.8 billion (Q4 2025), and $57.1 billion (Q3 2025), per Business Quant data.